Bharat Biotech's Covid-19 nasal vaccine to cost ₹800 in pvt market, ₹325 for govt supplies
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.